# To Investigate the Effect of Esketamine Hydrochloride on Pulmonary Complications

> **NCT06467513** · PHASE4 · RECRUITING · sponsor: **Zhang XIao Mei** · enrollment: 102 (estimated)

## Conditions studied

- Heart Diseases
- Heart Valve Diseases

## Interventions

- **DRUG:** Esketamine hydrochloride injection

## Key facts

- **NCT ID:** NCT06467513
- **Lead sponsor:** Zhang XIao Mei
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2025-05
- **Final completion:** 2025-05
- **Target enrollment:** 102 (ESTIMATED)
- **Last updated:** 2024-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06467513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06467513, "To Investigate the Effect of Esketamine Hydrochloride on Pulmonary Complications". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06467513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*